RUA’s global commercialisation partner for its range of large bore vascular grafts has been announced as Corcym SRL. Corcym is the heart valve business bought out from Sorin/Livanova in 2021 and is a specialist cardiovascular medical device company with complementary products – like sutureless/minimally invasive aortic valves, mechanical heart valves, aortic prostheses and mitral valves and repair devices. RUA Vascular’s products for straight and aortic root grafts will fit perfectly into Corcym ....
25 Jan 2023
Commercialisation partnership signed
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Commercialisation partnership signed
RUA Life Sciences Plc (RUA:LON) | 10.2 -0.1 (-4.7%) | Mkt Cap: 6.36m
- Published:
25 Jan 2023 -
Author:
Andy Smith -
Pages:
5
RUA’s global commercialisation partner for its range of large bore vascular grafts has been announced as Corcym SRL. Corcym is the heart valve business bought out from Sorin/Livanova in 2021 and is a specialist cardiovascular medical device company with complementary products – like sutureless/minimally invasive aortic valves, mechanical heart valves, aortic prostheses and mitral valves and repair devices. RUA Vascular’s products for straight and aortic root grafts will fit perfectly into Corcym ....